
Ajooni Biotech Limited has informed the Exchange regarding a press release dated November 18, 2024, titled "Ajooni Biotech Reports Strong Q2 FY25 Result With Growth Of 52% In PAT On Yearly Basis".
Filed with NSE ·

Ajooni Biotech Limited has informed the Exchange regarding a press release dated November 18, 2024, titled "Ajooni Biotech Reports Strong Q2 FY25 Result With Growth Of 52% In PAT On Yearly Basis".
6ix hasn’t read this filing yet.
Follow Ajooni Biotech into a list and get an email when it puts out news.
Follow Ajooni Biotech